Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-75
SponsorPeking Union Medical College Hospital

About this trial

The characteristics of the intestinal microbiota in high-risk colorectal polyp recurrence and their relationship with disease pathogenesis have not yet been fully elucidated. This study aims to analyze the microbial community characteristics in the intestinal mucosal tissue of patients after polypectomy with recurrence of colorectal polyps. Additionally, this research holds significant importance for understanding the etiology of adenoma recurrence and develop a microbiota and metabolite-based predicting tool.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients aged 40-75 years who undergo the colonoscopy with at least 1 advanced premalignant polyps or ≥ 3 adenoma

Disqualifiers

patient with severe physical diseases that prevented them from adhering to the examination requirements,

patient with coagulopathy or other contraindications for biopsy or polypectomy,

patient with previous surgical procedures on the gastrointestinal tract,

presence of colorectal cancer or other malignant tumor at baseline

Trial population

patients with high-risk colorectal polyps

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

150 Participants
are grouped into 1 trial group
Group A: Patients who undergo colonoscopy with precence of high-risk colorectal polyps

Trial outcomes

Primary outcomes

1

The characteristics of the intestinal microbiota in patients with high-risk colorectal polyp recurrence

Analyze the characteristics of the microbiota within the intestinal mucosal tissue of patients with high-risk colorectal polyp recurrence or without recurrence.

Time frame
24 months

Secondary outcomes

1

Development and validation of Microbiota and metabolite-based model predicting recurrence of high-risk colorectal polyps after polypectomy

Select the recurrence and non-recurrence of polyps during the follow-up period , and develop and validate the recurrence prediction model according to the differences in intestinal mucosal flora and host gene expression levels.

Time frame
36 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.